Insights That
Instill Confidence

As a premier strategy consulting firm, we provide guidance on critical business issues to life science industry leaders – combining deep industry knowledge with strong analytical rigor to drive strategic decision-making.

Learn More

We provide solutions to challenging problems.

Learn More About Our Consulting Services
About Us
About Us

We deliver
premium quality with a partnership mindset.

We achieve high-impact results for our clients around the globe and across all areas of life sciences.

Learn More

Triangle Insights Group is led by a team of seasoned executives with decades of life sciences experience in management consulting and industry.

Meet Our Team

PartnerGautam Aggarwal

PartnerGautam Aggarwal

Gautam has twenty years of pharmaceutical consulting experience and focuses on providing strategic guidance to clients with a focus on pricing and market access.

  • M.B.A. from the Fuqua School of Business at Duke
  • M.S. and a B.S. in Bio-Statistics from UNC-Chapel Hill

PartnerChristopher Apolito

PartnerChristopher Apolito

Chris Apolito has over 25 years of pharmaceutical and strategy consulting experience, with positions in discovery research, business development, and management consulting.

  • M.B.A. from the University of North Carolina Kenan-Flagler Business School
  • M.S. from the University of Buffalo
  • B.S. in Biochemistry from the University of Rochester

PartnerBarrett Rankin

PartnerBarrett Rankin

Barrett Rankin has led a wide spectrum of strategic engagements for life science industry clients, ranging from large multinational firms to venture-backed start-ups.

  • M.B.A. from the Tuck School of Business at Dartmouth College
  • B.A. from the University of Virginia
Insights

Insights

Whitepaper

White Paper Biosimilars Commercialization: Lessons Learned from Adalimumab and Four Necessary Approaches

Download White Paper
Whitepaper

White Paper IRA Drug Price Negotiations: Key Competitive Considerations for Innovators

Download White Paper
Whitepaper

White Paper A Tale of Two Companies: Observations from Back-to-Back Gene Therapy Approvals in Sickle Cell Disease and Implications for Future Innovators

Download White Paper
Updates

Updates

Press Release Triangle Insights Group’s Parent Company, TrialCard, Rebrands as Mercalis

September 20, 2023

We are thrilled to announce that TrialCard, the parent company of Triangle Insights Group, has changed its name to Mercalis. The name change reflects the brand’s evolution into an integrated life sciences commercialization partner.

Learn More

Press Release Triangle Insights Group Announces Promotion of Sarah Jims

September 6, 2023

Triangle Insights Group has announced a promotion that recognizes high achievement and further strengthens the firm’s senior leadership team. Triangle has named Sarah Jims a Partner.

Learn More

Press Release Triangle Insights Group Strengthens New York Team With Hiring of New Principal

May 9, 2023

Triangle Insights Group today announced the appointment of Heather Martin to Principal. The hiring of Martin, who has 15 years of experience in biotechnology, pharmaceuticals, and healthcare strategy, will strengthen both Triangle’s New York City office and its senior leadership team.

Learn More
Skip to toolbar